{"id":245355,"date":"2026-09-15T09:38:47","date_gmt":"2026-09-15T04:08:47","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=245355"},"modified":"2026-09-15T09:38:47","modified_gmt":"2026-09-15T04:08:47","slug":"why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/","title":{"rendered":"NEPHROCARE HEALTH SERV L (NEPHROPLUS) 52 Week High Streak: Second Straight Session at Rs 770"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/nephroplus\/nephrocare-health-serv-l-share-price-today\">NEPHROCARE HEALTH SERV L (NEPHROPLUS)<\/a> share price reached a fresh 52-week high of Rs 770 today and later stood at Rs 757.95, down 1.12% from the previous close. Market cap was Rs 7,708.35 crore.<\/em><\/div>\n<div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><strong>NEPHROCARE HEALTH SERV L 52 Week High Streak:<\/strong> <a href=\"https:\/\/univest.in\/stocks\/nephroplus\/nephrocare-health-serv-l-share-price-today\">NEPHROCARE HEALTH SERV L (NEPHROPLUS)<\/a> has now set a fresh 52-week high for its second straight session, with the stock rising 1.42% across the streak and touching Rs 770 as the latest peak. The latest figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for the continued move.<\/p>\n<p style=\"margin-top:0!important;\">At 15 September 2026 at 9:22 AM IST, the stock last traded at Rs 757.95 versus a previous close of Rs 766.55, after opening at Rs 770 and moving between Rs 748.45 and Rs 770. Turnover stood at Rs 0.23 crore and market capitalisation at Rs 7,708.35 crore. For readers, the value lies less in one session\u2019s high and more in the fact that NEPHROPLUS has now printed a fresh one-year high on consecutive sessions, which makes the streak itself the key signal to follow.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#NEPHROCARE_HEALTH_SERV_L_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"NEPHROCARE HEALTH SERV L 52 Week High Streak: Consecutive High Analysis\">NEPHROCARE HEALTH SERV L 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#NEPHROCARE_HEALTH_SERV_L_NEPHROPLUS_Fundamental_Analysis\" title=\"NEPHROCARE HEALTH SERV L (NEPHROPLUS) Fundamental Analysis\">NEPHROCARE HEALTH SERV L (NEPHROPLUS) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching_NEPHROCARE_HEALTH_SERV_L\" title=\"Why Investors Are Watching NEPHROCARE HEALTH SERV L\">Why Investors Are Watching NEPHROCARE HEALTH SERV L<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#About_NEPHROCARE_HEALTH_SERV_L\" title=\"About NEPHROCARE HEALTH SERV L\">About NEPHROCARE HEALTH SERV L<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#Track_NEPHROCARE_HEALTH_SERV_L_on_Univest\" title=\"Track NEPHROCARE HEALTH SERV L on Univest\">Track NEPHROCARE HEALTH SERV L on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#How_many_sessions_has_NEPHROCARE_HEALTH_SERV_L_been_setting_fresh_52-week_highs\" title=\"How many sessions has NEPHROCARE HEALTH SERV L been setting fresh 52-week highs?\">How many sessions has NEPHROCARE HEALTH SERV L been setting fresh 52-week highs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#What_is_the_cumulative_move_across_the_NEPHROCARE_HEALTH_SERV_L_52_Week_High_Streak\" title=\"What is the cumulative move across the NEPHROCARE HEALTH SERV L 52 Week High Streak?\">What is the cumulative move across the NEPHROCARE HEALTH SERV L 52 Week High Streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#What_was_the_latest_52-week_high_for_NEPHROPLUS\" title=\"What was the latest 52-week high for NEPHROPLUS?\">What was the latest 52-week high for NEPHROPLUS?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#Did_the_latest_trading_data_confirm_a_company-specific_catalyst\" title=\"Did the latest trading data confirm a company-specific catalyst?\">Did the latest trading data confirm a company-specific catalyst?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#How_did_NEPHROCARE_HEALTH_SERV_L_trade_during_the_session\" title=\"How did NEPHROCARE HEALTH SERV L trade during the session?\">How did NEPHROCARE HEALTH SERV L trade during the session?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#Is_NEPHROCARE_HEALTH_SERV_L_expensive_compared_with_peers\" title=\"Is NEPHROCARE HEALTH SERV L expensive compared with peers?\">Is NEPHROCARE HEALTH SERV L expensive compared with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#What_does_the_companys_profitability_profile_show\" title=\"What does the company\u2019s profitability profile show?\">What does the company\u2019s profitability profile show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#What_should_investors_monitor_next\" title=\"What should investors monitor next?\">What should investors monitor next?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-nephrocare-health-serv-l-share-52-week-consecutive-high-2026\/#Track_NEPHROCARE_HEALTH_SERV_L_NEPHROPLUS_Share_Price_on_Univest\" title=\"Track NEPHROCARE HEALTH SERV L (NEPHROPLUS) Share Price on Univest\">Track NEPHROCARE HEALTH SERV L (NEPHROPLUS) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"NEPHROCARE_HEALTH_SERV_L_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>NEPHROCARE HEALTH SERV L 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 757.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 766.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -8.6 (-1.12%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 770<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 770<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 748.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.23 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,708.35 crore<\/td>\n<\/tr>\n<\/table>\n<p>NEPHROCARE HEALTH SERV L (NEPHROPLUS) traded at Rs 757.95 versus the previous close of Rs 766.55, a fall of 1.12%. The stock opened at Rs 770, reached a high of Rs 770 and touched a low of Rs 748.45.<\/p>\n<p>The NEPHROCARE HEALTH SERV L share price today showed a softer intraday position versus the previous close, even though the stock had already extended its 52-week-high run. It last traded at Rs 757.95, down Rs 8.60 or 1.12% from Rs 766.55. The day opened at Rs 770, matched the 52-week high at Rs 770, and then moved down to a low of Rs 748.45, placing the current price in the lower half of the day\u2019s range.<\/p>\n<p>That price path matters because the stock still sits inside a broader repeated-high pattern rather than a one-off spike. Turnover was Rs 0.23 crore, while market capitalisation stood at Rs 7,708.35 crore. In stock market coverage, NEPHROCARE HEALTH SERV L share price today needs to be read alongside the streak itself: the fresh one-year high was first triggered in the earlier session, and today\u2019s trade shows how the stock is moving after that reference point. For investors scanning Stocks In News Today or 52 Week High Stocks, the distinction between the streak and a single-day breakout is important.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>NEPHROCARE HEALTH SERV L\u2019s repeated 52-week highs show that the stock has continued to trade at new one-year peaks for a second straight session, with the cumulative streak move now at 1.42%. The latest high of Rs 770 is also the most recent reference point for the move, and the comparison with the earlier peak is straightforward: the stock has repeated the same one-year high pattern across consecutive sessions rather than merely testing it once.<\/p>\n<p>What this means for readers is that the NEPHROCARE HEALTH SERV L 52 Week High Streak is an event-driven pattern, not a statement of why the move is happening. The numbers confirm the price behaviour, but they do not identify a company-specific trigger. That is why the more useful question is whether the streak continues to hold above the prior breakout level and whether subsequent trading preserves the pattern of higher reference points. In the language of stock performance, this is a repeated one-year high, not a lifetime record unless an explicit all-time high is provided.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"NEPHROCARE_HEALTH_SERV_L_NEPHROPLUS_Fundamental_Analysis\"><\/span><strong>NEPHROCARE HEALTH SERV L (NEPHROPLUS) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,708.35 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">100.32x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.8x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.18%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7.64<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 112.78<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>NEPHROCARE HEALTH SERV L (NEPHROPLUS) fundamental metrics show P\/E 100.32x, P\/B 6.8x, ROE 9.22%, ROCE 16.18%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>NEPHROCARE HEALTH SERV L has a market capitalisation of Rs 7708.35 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 100.32x, P\/B at 6.8x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.22% and ROCE of 16.18%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7.64, book value per share of Rs 112.78, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 46.95x, median ROE of 12.95%, median ROCE of 15.7%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Hospital &amp; Healthcare Services<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">100.32x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">46.95x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">105.02x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.18x to 1,570.12x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.8x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.95%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.18%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,708.35 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 475.97 crore<\/td>\n<\/tr>\n<\/table>\n<p>NEPHROCARE HEALTH SERV L (NEPHROPLUS) is classified under sector: Healthcare and industry: Hospital &amp; Healthcare Services.<\/p>\n<p>NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a P\/E ratio of 100.32x, which is above the benchmark median of 46.95x, a difference of +113.67%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a ROE of 9.22%, which is below the benchmark median of 12.95%, a difference of -28.8%. NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a ROCE of 16.18%, which is above the benchmark median of 15.7%, a difference of +3.06%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/thyrocare\/thyrocare-technologies-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Thyrocare Technologies Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">THYROCARE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8,727.03<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">49.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.05<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kovai\/kovai-medical-center-and-hospital-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Kovai Medical Center &amp; Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KOVAI<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6,788.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.89<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/jlhl\/jupiter-life-line-hospitals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Jupiter Life Line Hospitals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">JLHL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9,143.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">48.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/yatharth\/yatharth-hospital-and-trauma-care-services-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Yatharth Hospital &amp; Trauma Care Services Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">YATHARTH<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9,311.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">51.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hcg\/healthcare-global-enterprises-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Healthcare Global Enterprises Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HCG<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10,353.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">454.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.77<\/td>\n<\/tr>\n<\/table>\n<p>NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a P\/E ratio of 100.32x compared with the displayed peer median of 49.5x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.22% compares with a peer median of 13.39% across the companies shown in the table. ROCE stood at 16.18% versus the displayed peer median of 15.7%, providing a capital-efficiency comparison. NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a market capitalisation of Rs 7,708.35 crore. Among the 5 peers shown, 4 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_NEPHROCARE_HEALTH_SERV_L\"><\/span><strong>Why Investors Are Watching NEPHROCARE HEALTH SERV L<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock has set a fresh 52-week high for its second straight session.<\/li>\n<li>The cumulative streak move is 1.42% across the repeated highs.<\/li>\n<li>The latest one-year peak stands at Rs 770.<\/li>\n<li>The healthcare valuation backdrop is mixed, with NEPHROCARE HEALTH SERV L trading above the industry median P\/E and P\/B.<\/li>\n<li>Turnover, market cap and profit-return ratios place the stock on investors\u2019 watchlists for stock performance tracking.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_NEPHROCARE_HEALTH_SERV_L\"><\/span><strong>About NEPHROCARE HEALTH SERV L<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>NEPHROCARE HEALTH SERV L operates in the Hospital &#038; Healthcare Services industry within the Healthcare sector. The company\u2019s current market capitalisation is Rs 7,708.35 crore, and its latest trading profile includes a P\/E ratio of 100.32, P\/B ratio of 6.8, ROE of 9.22% and ROCE of 16.18%.<\/p>\n<p>For readers comparing healthcare companies, the business sits in a segment where market capitalisation, valuation and operating returns can differ widely across listed peers. That makes NEPHROCARE HEALTH SERV L Stock News relevant not only because of the streak, but also because of how its valuation and returns compare with the broader industry set.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_NEPHROCARE_HEALTH_SERV_L_on_Univest\"><\/span><strong>Track NEPHROCARE HEALTH SERV L on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Track NEPHROCARE HEALTH SERV L on Univest for the latest Share Price Today, Stock News, Market Cap updates and company-specific coverage. The NEPHROCARE HEALTH SERV L 52 Week High Streak will remain relevant as long as the stock keeps printing new one-year highs across sessions.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_NEPHROCARE_HEALTH_SERV_L_been_setting_fresh_52-week_highs\"><\/span><strong>How many sessions has NEPHROCARE HEALTH SERV L been setting fresh 52-week highs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> NEPHROCARE HEALTH SERV L has set a fresh 52-week high for its second straight session. The repeated-high pattern is the key event, and the latest peak remains Rs 770.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_cumulative_move_across_the_NEPHROCARE_HEALTH_SERV_L_52_Week_High_Streak\"><\/span><strong>What is the cumulative move across the NEPHROCARE HEALTH SERV L 52 Week High Streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The cumulative move across the streak is 1.42%. That figure captures the total change over the repeated-high run rather than just the latest intraday move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_latest_52-week_high_for_NEPHROPLUS\"><\/span><strong>What was the latest 52-week high for NEPHROPLUS?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest 52-week high was Rs 770. The stock touched that level again while extending its second straight session of fresh one-year highs. The stock moved -1.12% so far today.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_the_latest_trading_data_confirm_a_company-specific_catalyst\"><\/span><strong>Did the latest trading data confirm a company-specific catalyst?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. The latest figures confirm the price pattern, but they do not establish a company-specific catalyst for the repeated highs. Investors should separate the price behaviour from the reason behind it.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_NEPHROCARE_HEALTH_SERV_L_trade_during_the_session\"><\/span><strong>How did NEPHROCARE HEALTH SERV L trade during the session?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock last traded at Rs 757.95 after opening at Rs 770 and moving between Rs 748.45 and Rs 770. It was down 1.12% versus the previous close of Rs 766.55.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_NEPHROCARE_HEALTH_SERV_L_expensive_compared_with_peers\"><\/span><strong>Is NEPHROCARE HEALTH SERV L expensive compared with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> On the latest numbers, NEPHROCARE HEALTH SERV L trades at 100.32 times earnings, which is above the healthcare industry median of 46.95 and above several peers such as Kovai Medical Center &amp; Hospital Ltd. and Artemis Medicare Services Ltd.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_companys_profitability_profile_show\"><\/span><strong>What does the company\u2019s profitability profile show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> NEPHROCARE HEALTH SERV L reports ROE of 9.22% and ROCE of 16.18%. ROCE is slightly above the industry median, while ROE is below the sector median, so investors may compare both metrics together.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next\"><\/span><strong>What should investors monitor next?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can monitor whether the stock continues to print new one-year highs, how it trades relative to Rs 770, and whether valuation remains supported by operating performance and sector context. The streak itself is the immediate focus.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_NEPHROCARE_HEALTH_SERV_L_NEPHROPLUS_Share_Price_on_Univest\"><\/span><strong>Track NEPHROCARE HEALTH SERV L (NEPHROPLUS) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/nephroplus\/nephrocare-health-serv-l-share-price-today\">NEPHROCARE HEALTH SERV L (NEPHROPLUS) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"How many sessions has NEPHROCARE HEALTH SERV L been setting fresh 52-week highs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"NEPHROCARE HEALTH SERV L has set a fresh 52-week high for its second straight session. The repeated-high pattern is the key event, and the latest peak remains Rs 770.\"}},{\"@type\":\"Question\",\"name\":\"What is the cumulative move across the NEPHROCARE HEALTH SERV L 52 Week High Streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The cumulative move across the streak is 1.42%. That figure captures the total change over the repeated-high run rather than just the latest intraday move.\"}},{\"@type\":\"Question\",\"name\":\"What was the latest 52-week high for NEPHROPLUS?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The latest 52-week high was Rs 770. The stock touched that level again while extending its second straight session of fresh one-year highs. The stock moved -1.12% so far today.\"}},{\"@type\":\"Question\",\"name\":\"Did the latest trading data confirm a company-specific catalyst?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. The latest figures confirm the price pattern, but they do not establish a company-specific catalyst for the repeated highs. Investors should separate the price behaviour from the reason behind it.\"}},{\"@type\":\"Question\",\"name\":\"How did NEPHROCARE HEALTH SERV L trade during the session?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock last traded at Rs 757.95 after opening at Rs 770 and moving between Rs 748.45 and Rs 770. It was down 1.12% versus the previous close of Rs 766.55.\"}},{\"@type\":\"Question\",\"name\":\"Is NEPHROCARE HEALTH SERV L expensive compared with peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"On the latest numbers, NEPHROCARE HEALTH SERV L trades at 100.32 times earnings, which is above the healthcare industry median of 46.95 and above several peers such as Kovai Medical Center & Hospital Ltd. and Artemis Medicare Services Ltd.\"}},{\"@type\":\"Question\",\"name\":\"What does the company\u2019s profitability profile show?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"NEPHROCARE HEALTH SERV L reports ROE of 9.22% and ROCE of 16.18%. ROCE is slightly above the industry median, while ROE is below the sector median, so investors may compare both metrics together.\"}},{\"@type\":\"Question\",\"name\":\"What should investors monitor next?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors can monitor whether the stock continues to print new one-year highs, how it trades relative to Rs 770, and whether valuation remains supported by operating performance and sector context. The streak itself is the immediate focus.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEPHROCARE HEALTH SERV L Share Price hits a new 52-week high at Rs 757.95, marking a -1.12% rise today. Market cap stands at Rs 7,708.35 crore.<\/p>\n","protected":false},"author":29,"featured_media":245354,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-245355","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["245354"],"rank_math_title":["NEPHROCARE HEALTH SERV L 52 Week High Streak: 2nd Session"],"rank_math_description":["NEPHROCARE HEALTH SERV L has set a fresh 52-week high for the second straight session. Read the streak move, valuation, sector and peer view."],"rank_math_focus_keyword":["NEPHROCARE HEALTH SERV L 52 Week High Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/NEPHROCARE_HEALTH_SERV_L_NEPHROPLUS_52_Week_High_Streak_Second_Straight_Session_at_Rs_770_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/245355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=245355"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/245355\/revisions"}],"predecessor-version":[{"id":245356,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/245355\/revisions\/245356"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/245354"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=245355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=245355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=245355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}